Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Oct 15, 2005 (Vol. 25, No. 18)

Welcome to the NIH Genetic Modification Clinical Research Information System

URL:www4.od.nih.gov/oba/RAC/GeMCRIS/GeMCRIS.htm
  • Great for researchers
  • Not for everyone
Interested in learning more about human gene transfer trials? What an amazing coincidence! These pages offer the same. OK, enough silliness. The NIH Genetic Modification Clinical Research Information System (GeMCRIS) provides a considerable amount of information on this subject, including general info, such as researcher and institution names, diseases/health situations being investigated, genes and delivery methods, and scientific as well as nonscientific summaries of the research. This is a geeky site, for sure. A boatload of information is available, but unless you are a researcher, there is little you will find of interest here.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »